Intragastric Balloons Market: Regulatory Framework, Regional Production Volume, Production Growth, and Opportunities to 2030

Intra-gastric Balloons Market Overview

Studies reveal that over 2 billion people are suffering from obesity and about 3 million people lose their lives each year due to obesity. Intra-gastric balloons have emerged as a boon for shedding weight and reducing obesity.

The healthcare sector is increasingly shifting towards non to minimally invasive procedures from surgical weight loss treatments, keeping patient convenience at top.

Faster approvals from regulatory bodies such as the US FDA and its associated treatment followed by the American Society for Metabolic and Bariatric Surgery are further standardizing the application of intra-gastric balloons.

Intra-gastric Balloons Market – Growth Trends

High adoption of minimally invasive surgeries by obese patients, owing to increased risks from invasive weight-loss treatments, is fueling the demand for intra-gastric balloons. Intra-gastric balloons are gaining a good reputation as they are cost-effective.

According to the American Society for metabolic and Bariatric Surgery (ASMBS), after receiving approval from the US FDS, more than 5000 implantation of intra-gastric balloon have been successfully processed.  

Involvement of robotics to help doctors for minimal invasive procedures is proving to be a perk in the healthcare sector. With the help of robots, pace of surgical operations has risen from 1.8% to 15%.

Moreover, the JAMA Network Open has discovered that colon operations conducted with help of robots were safer than open operations. Furthermore, market players are innovating intra-gastric balloons to further reduce the cost of expensive surgeries. 

Case in point, Allurion technologies has developed the world’s first swallowable non-invasive intra-gastric balloons.

Intra-gastric Balloons Market – Growth Restraints

Several medical insurance companies do not involve endoscopic intra-gastric balloons in their reimbursement policies, restricting from undergoing this procedure. Side effects caused due to intra-gastric balloons such as gastric ulcers, erosions, and nausea are a major challenge for market players. Further, patients have to stick to strict diet rules while the balloon is in place.

Impact of COVID-19 on Intra-gastric Balloons Market

The COVID-19 pandemic is having an adverse impact on the intra-gastric balloons market. With governments across the world imposing nationwide lockdowns, several healthcare units have been shut down.

Gastroenterologists are kept away from frontline operations for COVID-19 treatment. Healthcare professionals, especially in Italy, are in process to carry out the removal of intra-gastric balloons which are in their maturity period, states the NCBI.

Healthcare professionals are taking utmost care for treatment at their personal clinics and are serving emergency patients to stop the spread of coronavirus. According to the British Journal of Surgery (BJS) Society, gastrointestinal surgeries have dropped by 90% during the pandemic.

Such notable decline in demand are hitting the profit margins of intra-gastric balloon manufacturers.

Intra-gastric Balloons Market – Regional Analysis

North America continues to remain in the vanguard of the intra-gastric balloons market, owing to rising cases of obesity and increasing adoption of bariatric procedures.

The region is tech center for healthcare center. Furthermore, rising investments in advanced healthcare in tandem with favorable reimbursement policies are creating conducive grounds for market players.

Asia Pacific (APAC) is projected to emerge as the most lucrative region in intra-gastric balloons market in coming years. Increasing government investments in healthcare sector in emerging countries such as India, and China are fueling market growth.
Additionally, rising trend of medical tourism and minimally non-invasive technologies in the region are attracting stakeholders.

Intra-gastric Balloons Market – Key Players

  • Allurion Technologies
  • Apollo Endosurgery
  • Districlass Medical
  • Helioscopie Medical Implants
  • Silimed
  • Lexel
  • Medsil
  • Obalon Therapeutics
  • ReShape Medical
  • Spatz
  • Life Partners Europe
  • Tulip Medical

Intra-gastric Balloons Market – Segmentation

By Product

  • Single Intra-gastric Balloons
  • Dual Intra-gastric Balloons
  • Triple Intra-gastric Balloons

By Filling Materials

  • Saline Filled Balloons
  • Gas Filled Balloons

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics

Browse More@ https://www.futuremarketinsights.com/reports/intragastric-balloons-market

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more